In 2025, Max Healthcare’s share price plateaued after an 800% rally as the company’s ROCE and EBITDA margins fell with new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback